Percutaneous ablation therapy for hepatocellular carcinoma: Current practice and future perspectives

Journal of the Chinese Medical Association

Volumn 68, Issue 4, 2005, Pages 155-159

  Huo, Teh Ia ^a,b   Huang, Yi Hsiang ^a,b   Wu, Jaw Ching ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Microwave coagulation therapy; Percutaneous acetic acid injection; Percutaneous ethanol injection; Radiofrequency ablation

Indexed keywords

ACETIC ACID; ALCOHOL; MICROSPHERE; SODIUM CHLORIDE; YTTRIUM 90;

ABDOMINAL PAIN; ALGORITHM; ARTIFICIAL EMBOLISM; CANCER LOCALIZATION; CANCER THERAPY; CHEMOEMBOLIZATION; CLINICAL TRIAL; CRYOTHERAPY; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; FEASIBILITY STUDY; FEVER; HUMAN; IMAGE ANALYSIS; INDIVIDUALIZATION; LASER COAGULATION; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MICROWAVE THERAPY; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PERCUTANEOUS ABLATION THERAPY; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SURVIVAL TIME; TUMOR NECROSIS; TUMOR VOLUME;

EID: 17244381293     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70239-4     Document Type: Review

References (55)

1. Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, ed. Liver Cancer. New York: Churchill Livingstone, 1997:13-28.
2. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139: 817-23.
3. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350:1142-3.
4. Chiu ST, Chiu JH, Lui WY, Chau GY, Loong CC, Wu CW. Prognostic factors affecting long-term survival after partial hepatectomy for human hepatocellular carcinoma. J Chin Med Assoc 1997;59:177-85.
5. Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl 2004;10(Suppl):91-7.
6. Ng KK, Lam CM, Poon RT, Ai V, Tso WK, Fan ST. Thermal ablative therapy for malignant liver tumors: a critical appraisal. J Gastroenterol Hepatol 2003;18:616-29.
7. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105:488-94.
8. Gaiani S, Celli N, Cecilioni L, Piscaglia F, Bolondi L. Percutaneous treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2003;17(Suppl):103-10.
9. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
10. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, Hamada E, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 1993;160:1023-8.
11. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, Ayuso C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993;18:1121-6.
12. Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, Salmi A, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer 1992;69:925-9.
13. Lencioni R, Pinto F, Armillotta N, Pinto F, Armillotta N, Di Giulio M, Marchi S, et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 1997;7:514-9.
14. Rizzi PM, Kane PA, Ryder SD, Ramage JK, Gane E, Tan KC, Portmann B, et al. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology 1994;107:1425-9.
15. Shuto T, Hirohashi K, Ikebe T, Mikami S, Yamamoto T, Kubo S, Wakasa K, et al. Additional hepatocellular carcinomas undetectable before surgery. World J Surg 2000;24:1566-9.
16. Kotoh K, Sakai H, Sakamoto S, Nakayama S, Satoh M, Morotomi I, Nawata H. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 1994;89:194-8.
17. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, Kosuge T. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34:707-13.
18. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy. Scand J Gastroenterol 2002;37:350-5.
19. Ohnishi K, Ohyama N, Ito S, Fujiwara K. Ultrasound guided intratumor injection of acetic acid for the treatment of small hepatocellular carcinoma. Radiology 1994;193:747-52.
20. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. Scand J Gastroenterol 2004;39:168-73.
21. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67-72.
22. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. Scand J Gastroenterol 2003;38:770-8.
23. Huo T, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. Aliment Pharmacol Ther 2004;19:1301-8.
24. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-61.
25. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-40.
26. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Deal Torre A, et al. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003;197:759-64.
27. Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST. Effectiveness of radiofrequency ablation for hepatocellular carcinomas larger than 3 cm in diameter. Arch Surg 2004;139:281-7.
28. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761-8.
29. Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, Cavallari A. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240:102-7.
30. Choi D, Lim HK, Kim MJ, Lee SH, Kim SH, Lee WJ, Lim JH, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004; 230:135-41.
31. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240: 900-9.
32. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206-22.
33. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-9.
34. Lam CM, Ng KK, Poon RT, Ai V, Yuen J, Fan ST. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg 2004;91:334-8.
35. Matsukawa T, Yamashita Y, Arakawa A, Nishiharu T, Urata J, Murakami R, Takahashi M, et al. Percutaneous microwave coagulation therapy in liver tumors. A 3-year experience. Acta Radiol 1997;38:410-5.
36. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817-25.
37. Shimada S, Hirota M, Beppu T, Matsuda T, Hayashi N, Tashima S, Takai E, et al. Complications and management of microwave coagulation therapy for primary and metastatic liver tumors. Surg Today 1998;28:1130-7.
38. Tabuse K, Katsumi M, Kobayashi Y, Noguchi H, Egawa H, Aoyama O, Kim H, et al. Microwave surgery: hepatectomy using a microwave tissue coagulator. World J Surg 1985;9: 136-43.
39. Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ, Huang JF. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001;221:167-72.
40. Yamanaka N, Tanaka T, Oriyama T, Furukawa K, Tanaka W, Okamoto E. Microwave coagulonecrotic therapy for hepatocellular carcinoma. World J Surg 1996;20:1076-81.
41. Itamoto T, Katayama K, Fukuda S, Fukuda T, Yano M, Nakahara H, Okamoto Y, et al. Percutaneous microwave coagulation therapy for primary or recurrent hepatocellular carcinoma: long-term results. Hepatogastroenterology 2001; 48:1401-5.
42. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999;85:1694-702.
43. Bartolozzi C, Lencioni R, Caramella D, Vignali C, Cioni R, Mazzeo S, Carrai M, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995;197:812-8.
44. Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001;92:1516-24.
45. Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, Ikeda K, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000;89:1245-51.
46. Huo TI, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann Oncol 2003;14: 1648-53.
47. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchiano A, Fornari F, Quaretti P, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000;217: 119-26.
48. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study. Ann Oncol 2004;15:775-80.
49. Huo TI, Lui WY, Wu JC, Huang YH, King KL, Loong CC, Lee PC, et al. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. World J Surg 2004;28:258-62.
50. Livraghi T, Meloni F, Morabito A, Vettori C. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl 2004;10 (Suppl):98-106.
51. Honda N, Guo Q, Uchida H, Ohishi H, Hiasa Y. Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy. Radiology 1994; 190:53-7.
52. Geschwind JF, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, Van Buskirk M, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004; 127(Suppl):194-205.
53. Christophi C, Muralidharan V. Treatment of hepatocellular carcinoma by percutaneous laser hyperthermia. J Gastroenterol Hepatol 2001;16:548-52.
54. Adam R, Majno P, Castaing D, Giovenardi R, Bismuth H. Treatment of irresectable liver tumours by percutaneous cryosurgery. Br J Surg 1998;85:1493-4.
55. Huo TI, Lee SD, Wu JC. Staging for hepatocellular carcinoma: look for a perfect classification system. J Hepatol 2004;40: 1041-2.